akkermansia muciniphila glp-1 Amazon.com: PADMURA Probiotic Supplement - 20 Billion CFU | 30 Veg Capsules | Prebiotic + Probiotic + Postbiotic Blend | Increases Production Designs for Health Introduces Akkermansia
Description
Among Medicare patients, 18% started with a GLP-1 while 24% used an SGLT2, reflecting the higher prevalence of cardiovascular conditions in seniors and the dual benefits SGLT2s provide in heart health
Discover the trends impacting CPG brands, foodservice, product innovation, and menu development.
About 19% of large employers now cover GLP-1 drugs used primarily for weight
Germany Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is valued at around $575.5 Mn in 2022 and is projected to reach $974.1 Mn by 2030, exhibiting a CAGR of 6.8% during the forecast period 2023-2030.
Financial Results and Expansion: Sigmas first-quarter sales up 17%, retail network sales up 14.7% year-over-year
Decode the landscape with our comprehensive analysis.
